All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
INMED PHARMACEUTICALS INC. Last Reported: 4/30/2024 Stock Symbol: INM

Business Address

SUITE 310, 815 W. HASTINGS STREET

VANCOUVER , BC CA V6C 1B4

Mailing Address

SUITE 310, 815 W. HASTINGS STREET

VANCOUVER , BC CA V6C 1B4
Phone Number: (604) 669-7207 / State Incorporated: BC / Fiscal Year End 6 /30

Balance Sheet

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019
Cash and Cash Equivalents $7,600,598.00 $9,534,922.00 -- $8,912,517.00 $9,604,057.00 $11,452,578.00 $9,350,427.00 $5,898,313.00 $11,279,964.00 $15,343,905.00 $7,363,126.00 $9,454,113.00 $10,020,853.00 $4,497,296.00 $5,805,809.00 -- -- -- $9,837,213.00
Accounts Receivable Net Current $207,681.00 $372,870.00 -- $260,399.00 $170,299.00 $81,647.00 $15,169.00 $70,554.00 $50,304.00 $14,842.00 $11,919.00 $70,300.00 $154,846.00 $51,873.00 $45,344.00 -- -- -- --
Inventory $1,193,952.00 $744,839.00 -- $1,616,356.00 $1,329,931.00 $1,613,506.00 $1,778,523.00 $1,420,382.00 $988,822.00 -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $1,018,686.00 $1,112,977.00 -- $498,033.00 $695,203.00 $826,931.00 $356,665.00 $1,311,539.00 $140,512.00 $322,352.00 $956,762.00 $1,326,526.00 $28,464.00 $524,196.00 $418,920.00 -- -- -- --
Total Current Assets $10,064,002.00 $11,810,070.00 -- $11,331,727.00 $11,842,545.00 $14,017,715.00 $11,542,909.00 $8,746,886.00 $12,505,026.00 $15,976,323.00 $8,378,269.00 $10,896,704.00 $10,249,388.00 $5,116,527.00 $6,312,457.00 -- -- -- --
Property Plant and Equipement $1,370,969.00 $1,481,102.00 -- -- $753,241.00 $703,922.00 $802,369.00 $1,002,846.00 $1,096,649.00 $304,934.00 $326,595.00 $347,892.00 $373,844.00 $384,529.00 $403,485.00 -- -- -- --
Intangible Assets Net $1,823,745.00 $1,864,292.00 -- $1,946,279.00 $1,986,826.00 $2,026,929.00 $2,067,922.00 $2,355,401.00 $2,400,831.00 $1,037,382.00 $1,061,697.00 $1,085,748.00 $1,109,535.00 $1,088,630.00 $1,086,655.00 -- -- -- --
Goodwill -- -- -- -- -- -- -- $2,023,039.00 $2,023,039.00 -- -- -- -- -- -- -- -- -- --
Other Assets $100,000.00 $100,000.00 -- $104,908.00 $147,489.00 $171,130.00 $171,130.00 $108,625.00 $109,175.00 $8,625.00 $14,655.00 $14,655.00 $14,655.00 $13,988.00 -- -- -- -- --
Total Assets $13,358,716.00 $15,255,464.00 -- $14,106,340.00 $14,730,101.00 $16,919,696.00 $14,584,330.00 $15,485,797.00 $19,383,720.00 $17,327,264.00 $9,781,216.00 $12,344,999.00 $11,747,422.00 $6,603,674.00 $7,802,597.00 -- -- -- --
Accounts Payable -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accrued Liabilities $167,523.00 $100,446.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $2,254,066.00 $2,483,253.00 -- $2,016,613.00 $2,342,463.00 $2,584,645.00 $3,576,390.00 $4,599,064.00 $5,216,407.00 $2,105,592.00 $2,404,649.00 $1,930,529.00 $4,156,609.00 $2,109,628.00 $1,924,279.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $37,507,306.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $128,569.00 $128,569.00 -- $128,569.00 $128,569.00 $128,569.00 $128,569.00 $128,569.00 $128,569.00 $128,569.00 $128,569.00 $128,569.00 $128,569.00 $-172,474.00 $-301,874.00 -- -- -- --
Accumulated Deficit $-107,100,000.00 $-105,400,000.00 -- $-101,400,209.00 $-101,061,818.00 $-99,063,874.00 $-96,962,787.00 $-85,582,564.00 $-82,106,899.00 $-77,824,085.00 $-74,852,470.00 $-71,593,717.00 $-68,492,242.00 $-66,248,460.00 $-64,649,381.00 -- -- -- --
Total Stockholders' Equity $11,104,650.00 $12,772,211.00 -- $12,089,727.00 $12,387,638.00 $14,335,051.00 $11,007,940.00 $10,886,733.00 $14,167,313.00 $15,221,672.00 $7,376,567.00 $10,414,470.00 $7,590,813.00 $4,494,046.00 $5,878,318.00 $7,072,509.00 $9,610,208.00 $11,469,596.00 $14,242,904.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $13,358,716.00 $15,255,464.00 -- $14,106,340.00 $14,730,101.00 $16,919,696.00 $14,584,330.00 $15,485,797.00 $19,383,720.00 $17,327,264.00 $9,781,216.00 $12,344,999.00 $11,747,422.00 $6,603,674.00 $7,802,597.00 -- -- -- --

Statement of Operations

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019
Total Revenues $3,314,663.00 $2,142,062.00 -- $4,135,561.00 $1,033,925.00 $790,571.00 $320,788.00 $574,677.00 $265,092.00 -- -- -- -- -- -- -- -- -- --
Cost of Revenues $2,416,417.00 -- -- $2,423,588.00 $1,415,068.00 $573,654.00 $235,034.00 $127,308.00 $153,537.00 -- -- -- -- -- -- -- -- -- --
Gross Profit $634,842.00 $345,384.00 -- $1,403,036.00 $192,511.00 $131,163.00 $-491,018.00 $182,277.00 $111,555.00 -- -- -- -- -- -- -- -- -- --
Research and Development $656,764.00 $1,901,884.00 -- $3,732,056.00 $878,303.00 $2,230,009.00 $1,378,653.00 $5,781,867.00 $2,537,070.00 $1,491,252.00 $5,338,084.00 $3,621,697.00 $1,849,104.00 $911,156.00 -- $4,843,656.00 $3,568,743.00 $1,961,912.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $2,133,782.00 $1,969,087.00 -- $9,781,823.00 $2,341,719.00 $2,365,284.00 $2,988,178.00 $11,038,206.00 $7,316,304.00 $2,892,651.00 $9,938,283.00 $6,631,982.00 $3,498,243.00 $1,563,925.00 -- $2,204,315.00 $5,386,458.00 $2,879,650.00 --
Loss from Operations -- -- -- $-7,947,622.00 $-7,609,231.00 $-2,101,087.00 $-3,510,200.00 $-10,730,094.00 $-7,254,429.00 -- -- -- -- -- -- -- -- -- --
Loss Before Income Taxes $-1,722,866.00 $-4,015,013.00 -- $-7,934,522.00 $-7,597,931.00 $-2,098,087.00 $-3,503,400.00 -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.18 $-0.71 -- $-3.25 $-3.53 $-0.91 $-4.06 -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 9,612,973 7,973,465 -- 2,448,458 3,328,191 1,583,073 865,619 -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.18 $-0.19 -- $-3.25 $-3.53 $-0.91 $-4.06 -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 6,961,938 5,650,828 -- 2,448,458 3,328,191 1,583,073 865,619 13,326,754 13,847,360 12,047,555 6,719,830 6,277,824 5,656,033 5,220,707 -- 5,220,707 5,220,707 5,220,707 --
Common Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Outstanding 6,344,970 5,667,970 -- 3,328,191 3,328,191 1,589,992 908,766 14,283,848 14,137,034 10,327,034 8,050,707 8,050,707 7,000,707 5,220,707 5,220,707 -- -- -- --
Common Stock Value $80,606,863.00 $79,936,633.00 -- $77,620,252.00 $77,620,252.00 $74,862,424.00 $72,671,392.00 $69,825,331.00 $69,096,601.00 $63,686,724.00 $60,587,417.00 $60,587,417.00 $58,008,112.00 $53,065,240.00 $53,065,240.00 -- -- -- --
Common Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- $1.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com